Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; none of the 34 sources its claims cite is checked for support yet.
Abstract
Chronic wounds are a major global health problem. Their management is difficult and costly, and the development of antibiotic resistance by both planktonic and biofilm-associated bacteria necessitates the use of alternative wound treatments. Honey is now being revisited as an alternative treatment due to its broad-spectrum antibacterial activity and the inability of bacteria to develop resistance to it. Many previous antibacterial studies have used honeys that are not well characterized, even in terms of quantifying the levels of the major antibacterial components present, making it difficult to build an evidence base for the efficacy of honey as an antibiofilm agent in chronic wound treatment. Here we show that a range of well-characterized New Zealand manuka-type honeys, in which two principle antibacterial components, methylglyoxal and hydrogen peroxide, were quantified, can eradicate biofilms of a range of Staphylococcus aureus strains that differ widely in their biofilm-forming abilities. Using crystal violet and viability assays, along with confocal laser scanning imaging, we demonstrate that in all S. aureus strains, including methicillin-resistant strains, the manuka-type honeys showed significantly higher anti-biofilm activity than clover honey and an isotonic sugar solution. We observed higher anti-biofilm activity as the proportion of manuka-derived honey, and thus methylglyoxal, in a honey blend increased. However, methylglyoxal on its own, or with sugar, was not able to effectively eradicate S. aureus biofilms. We also demonstrate that honey was able to penetrate through the biofilm matrix and kill the embedded cells in some cases. As has been reported for antibiotics, sub-inhibitory concentrations of honey improved biofilm formation by some S. aureus strains, however, biofilm cell suspensions recovered after honey treatment did not develop resistance towards manuka-type honeys. New Zealand manuka-type honeys, at the concentrations they can be applied in wound dressings are highly active in both preventing S. aureus biofilm formation and in their eradication, and do not result in bacteria becoming resistant. Methylglyoxal requires other components in manuka-type honeys for this anti-biofilm activity. Our findings support the use of well-defined manuka-type honeys as a topical anti-biofilm treatment for the effective management of wound healing.
Overview
CoChat Summary
TL;DR
Well-characterized New Zealand manuka-type honeys prevented and eradicated *Staphylococcus aureus* biofilms, including MRSA strains, more effectively than clover honey or an isotonic sugar solution. Methylglyoxal alone or with sugar did not reproduce the anti-biofilm activity, indicating other honey components are required.
Key findings
- Manuka-type honeys inhibited planktonic growth and biofilm formation: 8% manuka honey and Medihoney, 16% manuka/kanuka honey, and 32% clover honey completely inhibited growth of all four *S. aureus* strains; the sugar solution only inhibited MW2 at 32%. Manuka honey at 8% reduced NCTC 8325 biofilm formation by ∼95%, while Medihoney and manuka/kanuka honey achieved ∼95% prevention at 16%.
- Manuka honey was most effective against established biofilms, eliminating almost all biofilm mass at 16%–32%; Medihoney and manuka/kanuka honey were consistently effective across all four strains only at 32%. Clover honey and sugar solution did not significantly reduce established biofilm mass until 32%, and sugar solution did not remove USA300 biofilm at 32%.
- Honey killed cells within biofilms: after 8% manuka honey, only ∼10% of cells were viable in remaining ATCC 25923 and USA300 biofilms, no ATP was detected from MW2, and NCTC 8325 viability was reduced by ∼80% even though biofilm biomass was unaffected. CLSM showed 32% manuka honey reduced Syto9-stained live biofilm biomass to 10%.
- MGO alone or with sugar did not effectively eradicate established biofilms; MGO at levels equivalent to 1–8% manuka/kanuka honey increased NCTC 8325 biofilm biomass ∼2-fold, and no tested MGO concentration (1–32%) significantly reduced established biofilm biomass. Sub-inhibitory honey enhanced biofilm formation in some strains (NCTC 8325: 1.5- and 2-fold with manuka and manuka/kanuka honey), but cells recovered after honey treatment did not develop resistance.
Methods
- Four well-characterized NZ honeys (monofloral manuka, Medihoney, manuka/kanuka, clover) plus an isotonic sugar solution were tested; MGO, DHA, and H₂O₂ levels were quantified. Four *S. aureus* strains were used: NCTC 8325 and ATCC 25923 (methicillin-sensitive), MW2 (HA-MRSA), and USA300 (CA-MRSA).
- Static crystal violet assays measured biofilm formation and elimination; BacTitre Glo ATP luminescence measured cell viability in biofilms; CLSM with Syto9/propidium iodide and COMSTAT quantified live/dead biofilm biomass. Resistance was assessed by recovering cells after sub-eliminatory honey treatment and testing growth and biofilm formation.
- Statistical analysis used D’Agostino-Pearson normality tests followed by One-Way ANOVA with Tukey test, significance at p < 0.05; assays generally used three biological replicates with three technical repeats.
Limitations
- The paper notes that incomplete displacement of Syto9 by propidium iodide means some dead cells retain Syto9 staining, so absolute live-cell levels detected in the Syto9 channel are somewhat overestimated. It also reports the BacTitre Glo detection limit at a luminescence reading below 1,000, equivalent to 10³ CFU/well, with no upper limit detected.
- Evident from the text: all experiments are in vitro static biofilm assays in microtitre plates, not animal or clinical wound models, so the findings do not directly demonstrate efficacy in chronic wounds.
- Evident from the text: the study tests a limited set of four *S. aureus* strains and four NZ honey samples, so generalizability to other strains, honey sources, or wound pathogens is not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
0 Valid · 0 Not valid · 17 Not checked · 90 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In some cases, biofilm biomass increased but cell viability did not, e.g., NCTC 8325 biofilms with low concentrations of manuka (2%) and manuka/kanuka honey (1–4%) (Fig. 5).”
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Results > The effect of NZ manuka-type honeys on cell viability within S. aureus biofilms
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“at 8% manuka honey treatment, the NCTC 8325 biofilm mass remained similar to the untreated control (p > 0.05; Fig. 5)”
- Also stated in: § The effect of NZ manuka-type honeys on cell viability within S. aureus biofilms · hedged
“Although NCTC 8325 biofilm biomass was seemingly unaffected at 8% manuka honey compared to the untreated control (Fig. 5)”
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Results > The effect of NZ manuka-type honeys on established S. aureus biofilms
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § The effect of NZ manuka-type honeys on cell viability within S. aureus biofilms · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“NCTC 8325, the most efficient biofilm former out of all tested strains, gave a slightly different response toward honey treatment compared to the other three strains.”
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Results > The effect of NZ manuka-type honeys on established S. aureus biofilms
plainstates an associationn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, Medihoney, clover honey and the sugar solution did not enhance biofilm formation by strain NCTC 8325 at any concentration tested.”
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Results > The effect of NZ manuka-type honeys on S. aureus biofilm formation
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, this strain was the least sensitive to the manuka-type honeys.”
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Results > The effect of NZ manuka-type honeys on established S. aureus biofilms
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
60 more claims
Create a free account to see all 107 claims and to verify the 32 references still open.
- It may state two separate claims as one. 36
- Probably not a substantial claim. 10
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Manuka honey prevents the formation of biofilms by many problematic wound pathogens, including Staphylococcus and Streptococcus species, Acinetobacter baumannii, Eschericia coli, Enterobacter cloacae and P. aeruginosa, and it eradicates established biofilms32–40.”
From Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa (2019) · cites this paper as [38]
In the citing paper
“However, the levels of reported anti-biofilm activity are not consistent among all studies (ranging from 12–50%), which is likely to be due to differences in the levels of the major antibacterial components in the honey.”
From Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa (2019) · cites this paper as [38]
In the citing paper
“The assay was performed and validity checked against a standard curve as previously described for Staphylococcus aureus38, with the modification of using CAMHB for P. aeruginosa biofilms.”
From Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa (2019) · cites this paper as [38]
In the citing paper
“While the sugar solution (control) was demonstrated to be similarly effective in biofilm prevention and eradication, this does not negate the use of honey over sugar solutions in clinical practice as sugar alone is not as effective at similar concentrations to honey against other common wound pathogens30,38,42–46.”
From Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa (2019) · cites this paper as [38]
In the citing paper
“Although MGO has been shown to have inhibitory action against established S. aureus and P. aeruginosa biofilms previously41, it is not solely responsible for the anti-biofilm activity of manuka-type honeys highlighting the importance of additional components in the honey that modulate activity38.”
From Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa (2019) · cites this paper as [38]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Results > The effect of MGO on S. aureus biofilm prevention
“MGO at medium (700 mg/kg) and high (900 mg/kg) levels at the equivalent concentration to 32% manuka-kanuka honey and Medihoney prevented approximately 50% and 75% biofilm formation, respectively (p < 0.05).”
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Materials and Methods > Honey samples
“| Manuka | Spring 2010 | Hokianga, Northland, NZ | Leptospermum scoparium var. incanum | 4277 | 958 | 0.34 | | Medihoney | Spring 2010 | Northland, NZ | Leptospermum scoparium var. incanum +Kunzea ericoides | 883 | 776 | 0.31 | | Manuka/kanuka | Summer 2010/11 | Hokianga, Northland, NZ | Leptospermum scoparium var. incanum +Kunzea ericoides | 652 | 161 | 0.68 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Results > Assessing the development of resistance to manuka-type honeys in S. aureus biofilms
“However, they were unable to grow planktonically when subsequently exposed to 8% manuka, or 16% Medihoney and manuka/kanuka honey (the MIC levels for these honeys).”
§ Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities > Results > The effect of NZ manuka-type honeys on the planktonic growth of S. aureus
“| Medihoney | 8 | 8 | 8 | 8 |”
Citations
Cites
Human skin wounds: A major and snowballing threat to public health and the economy
Sen, C. K., Gordillo, G. M., Roy, S., Kirsner, R., Lambert, L., Hunt, T. K., Gottrup, F., Gurtner, G. C., & Longaker, M. T. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00543.x · Cited by 2,965
A modified microtiter-plate test for quantification of staphylococcal biofilm formation
Stepanović, S., Vuković, D., Dakić, I., Savić, B., & Švabić-Vlahović, M. (2000) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(00)00122-6 · Cited by 2,550
Christensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M., & Beachey, E. H. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.996-1006.1985 · Cited by 2,255
Quantification of biofilm structures by the novel computer program comstat
Heydorn, A., Nielsen, A. T., Hentzer, M., Sternberg, C., Givskov, M., Ersbøll, B. K., & Molin, S. (2000) · Microbiology · doi:10.1099/00221287-146-10-2395 · Cited by 2,179
Survival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Growing and Analyzing Static Biofilms
Merritt, J. H., Kadouri, D. E., & O'Toole, G. A. (2006) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc01b01s00 · Cited by 1,086
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
The world of subinhibitory antibiotic concentrations
Davies, J., Spiegelman, G. B., & Yim, G. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.006 · Cited by 750
A Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Research works printed but not linked: 1
- Cooper R Using honey to inhibit wound pathogens Nursing Times 46 2008 104 48 49 18293880
Cited by
Treatment Strategies for Infected Wounds
Negut, I., Grumezescu, V., & Grumezescu, A. M. (2018) · Molecules · doi:10.3390/molecules23092392 · Cited by 739
Stiefel, P., Schmidt-Emrich, S., Maniura-Weber, K., & Ren, Q. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0376-x · Cited by 710
The Composition and Biological Activity of Honey: A Focus on Manuka Honey
Alvarez-Suarez, J., Gasparrini, M., Forbes-Hernández, T., Mazzoni, L., & Giampieri, F. (2014) · Foods · doi:10.3390/foods3030420 · Cited by 485
Antibiofilm Activity of Plant Polyphenols
Slobodníková, L., Fialová, S., Rendeková, K., Kováč, J., & Mučaji, P. (2016) · Molecules · doi:10.3390/molecules21121717 · Cited by 325
Oryan, A., Alemzadeh, E., & Moshiri, A. (2016) · Journal of Tissue Viability · doi:10.1016/j.jtv.2015.12.002 · Cited by 309
Metadata
- Authors
- Lu, J., Turnbull, L., Burke, C. M., Liu, M., Carter, D. A., Schlothauer, R. C., Whitchurch, C. B., & Harry, E. J.
- Affiliations
- The ithree institute, University of Technology Sydney, Sydney, NSW, Australia
- University of Technology Sydney (AU)
- The University of Sydney (AU)
- Comvita (New Zealand) (NZ)
- Corresponding author
- Harry, Elizabeth J.
- ORCID
- Venue
- PeerJ
- Publisher
- PeerJ
- Published
- 2014-03-25
- Volume
- 2
- Pages
- e326
- ISSN
- 2167-8359 (ISSN-L)
- PMC
- PMC3970805
- OpenAlex
- W2013770888
- Cited by
- 184
- References
- 62
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 12 · 2023: 14 · 2022: 13 · 2021: 19 · 2020: 25 · 2019: 19 · 2018: 16 · 2017: 14 · 2016: 20 · 2015: 10 · 2014: 7
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- PeerJ (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OPUS - Open Publications of UTS Scholars (University of Technology Sydney) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- University of Technology Sydney
- Comvita
- Australian Research Council (LP0990949)
- National Health and Medical Research Council (571905)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Insect Science › Bee Products Chemical Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- manuka honey, Staphylococcus aureus, biofilm eradication, antibiofilm activity, methylglyoxal, hydrogen peroxide, chronic wounds, methicillin-resistant Staphylococcus aureus, antibiotic resistance, clover honey
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities. https://app.cochat.ai/papers/10.7717/peerj.326
- The paper
- Lu, J., Turnbull, L., Burke, C. M., Liu, M., Carter, D. A., Schlothauer, R. C., Whitchurch, C. B., & Harry, E. J. (2014). Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities. PeerJ. https://doi.org/10.7717/peerj.326
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.